Twist Bioscience
TWST
155.65
-11.32
-6.78%
Twist Bioscience
US · TWST
#1258 by market cap
Listed 2018
155.65
-11.32
-6.78%
Live - 5344 symbols - heartbeat 24s ago
· 2026-10-08 06:50
Pre-market
151.80
-2.47%
After-hours
155.50
-0.10%
Overnight
154.61
-0.67%
- Market cap
- 10.32B
- P/E (TTM)i
- -69.80
- P/Bi
- 23.15
- EPSi
- -1.30
- Div yieldi
- 0.00%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on TWST?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
114.25 -26.6%
Price target rangecurrent 155.65
Low45.00
Avg114.25
High190.00
Buy 78%
Hold 11%
Sell 11%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | Leerink Partners | -- | BUY | 190.00 |
| 2026-09-18 | BWS Financial | -- | SELL | 45.00 |
| 2026-09-17 | Leerink Partners | -- | BUY | 160.00 |
| 2026-09-09 | BWS Financial | -- | SELL | 45.00 |
| 2026-08-05 | Piper Sandler | -- | BUY | 115.00 |
| 2026-08-04 | Baird | -- | BUY | 115.00 |
| 2026-08-03 | TD Cowen | -- | BUY | 115.00 |
| 2026-08-03 | CCORF | -- | BUY | 120.00 |
| 2026-08-03 | William Blair | -- | BUY | -- |
| 2026-08-03 | Barclays | -- | BUY | 112.00 |
| 2026-07-17 | Leerink Partners | -- | BUY | 110.00 |
| 2026-07-16 | Leerink Partners | -- | BUY | 110.00 |
| 2026-07-13 | CCORF | -- | BUY | 120.00 |
| 2026-07-06 | Evercore | -- | HOLD | 102.00 |
| 2026-06-29 | Guggenheim | -- | BUY | 107.00 |
| 2026-06-24 | Barclays | -- | BUY | 95.00 |
| 2026-06-15 | TD Cowen | -- | BUY | 89.00 |
| 2026-06-15 | CCORF | -- | BUY | 90.00 |
| 2026-06-11 | Piper Sandler | -- | BUY | 85.00 |
| 2026-05-26 | William Blair | -- | BUY | -- |
| 2026-05-26 | Barclays | -- | BUY | 65.00 |
| 2026-05-22 | TD Cowen | -- | BUY | 68.00 |
| 2026-05-22 | Guggenheim | -- | BUY | 60.00 |
| 2026-05-05 | Baird | -- | BUY | 65.00 |
| 2026-05-05 | Leerink Partners | -- | BUY | 70.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Buy
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Evercore moved from Buy to Hold on 2026-07-06.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-06 | Evercore | BUY → HOLD | 102.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-08-03 | -- | ±19.17% | +10.39% (in line) |
| 2026/Q2 | 2026-05-04 | -- | ±15.27% | -6.97% (in line) |
| 2026/Q1 | 2026-02-02 | -- | ±17.32% | +13.98% (in line) |
| 2025/Q4 | 2025-11-14 | -- | ±18.25% | -10.13% (in line) |
| 2025/Q3 | 2025-08-04 | -- | ±22.88% | -10.30% (in line) |
| 2025/Q2 | 2025-05-05 | -- | ±15.16% | -8.44% (in line) |
| 2025/Q1 | 2025-02-03 | -- | ±17.15% | +0.73% (in line) |
| 2024/Q4 | 2024-11-18 | -- | ±23.08% | +12.31% (in line) |
| 2024/Q3 | 2024-08-02 | -- | ±22.44% | -19.00% (in line) |
| 2024/Q2 | 2024-05-02 | After close | ±17.01% | +28.74% (beat) |
| 2024/Q1 | 2024-02-02 | -- | ±19.08% | +10.01% (in line) |
| 2023/Q3 | 2023-08-04 | -- | ±25.54% | +11.18% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 06:50:15 · For reference only, not investment advice and not tailored to your situation.